DK0626381T3 - Fremstilling af form 1 ranitidinhydrochlorid - Google Patents

Fremstilling af form 1 ranitidinhydrochlorid

Info

Publication number
DK0626381T3
DK0626381T3 DK93304182.4T DK93304182T DK0626381T3 DK 0626381 T3 DK0626381 T3 DK 0626381T3 DK 93304182 T DK93304182 T DK 93304182T DK 0626381 T3 DK0626381 T3 DK 0626381T3
Authority
DK
Denmark
Prior art keywords
ranitidine hydrochloride
preparation
prepared
volume
solution
Prior art date
Application number
DK93304182.4T
Other languages
Danish (da)
English (en)
Inventor
Teng-Ko Ngooi
Casimir Antczak
Jeffrey David Mcgolrick
James Lorne Anthony Tindall
Original Assignee
Torcan Chemical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torcan Chemical Ltd filed Critical Torcan Chemical Ltd
Application granted granted Critical
Publication of DK0626381T3 publication Critical patent/DK0626381T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
DK93304182.4T 1993-04-01 1993-05-28 Fremstilling af form 1 ranitidinhydrochlorid DK0626381T3 (da)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US08/041,354 US5338871A (en) 1991-12-20 1993-04-01 Preparation of form 1 ranitidine hydrochloride
EP93304182A EP0626381B1 (de) 1993-04-01 1993-05-28 Herstellung der Form 1 von Ranitidin Hydrochlorid
CA002099530A CA2099530C (en) 1993-04-01 1993-07-02 Preparation of form 1 ranitidine hydrochloride
AU41794/93A AU674006B2 (en) 1993-04-01 1993-07-06 Preparation of form 1 ranitidine hydrochloride
HU9301980A HU214334B (hu) 1993-04-01 1993-07-08 Eljárás ranitidin-hidroklorid 1 kristályformájának előállítására
ZA934995A ZA934995B (en) 1993-04-01 1993-07-12 Preparation of form 1 ranitidine hydrochloride
NZ260551A NZ260551A (en) 1993-04-01 1994-05-18 Preparation of form 1 ranitidine hcl crystals

Publications (1)

Publication Number Publication Date
DK0626381T3 true DK0626381T3 (da) 1995-10-02

Family

ID=27560579

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93304182.4T DK0626381T3 (da) 1993-04-01 1993-05-28 Fremstilling af form 1 ranitidinhydrochlorid

Country Status (11)

Country Link
US (1) US5338871A (de)
EP (1) EP0626381B1 (de)
AT (1) ATE119894T1 (de)
AU (1) AU674006B2 (de)
CA (1) CA2099530C (de)
DE (1) DE69300088T2 (de)
DK (1) DK0626381T3 (de)
ES (1) ES2069446T3 (de)
HU (1) HU214334B (de)
NZ (1) NZ260551A (de)
ZA (1) ZA934995B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4341310A1 (de) * 1993-12-03 1995-06-08 Hexal Pharma Gmbh Tablette oder Kapsel mit einem Gehalt an stabilem Ranitidinhydrochlorid Form 1
CA2120874E (en) * 1994-04-08 2002-01-08 Keshava Murthy Form of form 1 ranitidine
US5670671A (en) * 1994-04-08 1997-09-23 Brantford Chemicals Inc. Process for the production of an improved form of form 1 ranitidine
NZ272054A (en) * 1994-05-13 1996-05-28 Ranbaxy Lab Ltd Process for producing form 1 ranitidine hydrochloride
IN181699B (de) * 1994-05-13 1998-09-05 Ranbaxy Lab Ltd
DE69504156T2 (de) * 1994-06-24 1998-12-24 Ranbaxy Laboratories, Ltd., New Delhi Verfahren zur Herstellung von Ranitidinhydrochlorid in der Kristallform 1
WO1996019232A1 (en) * 1994-12-19 1996-06-27 Lauteral Limited Combinations of ranitidine hydrochloride-form 1 and bismuth compounds
US5663381A (en) * 1995-04-21 1997-09-02 Hexal Pharmaceuticals, Inc. Process for preparing form 1 ranitidine hydrochloride
US5686588A (en) * 1995-08-16 1997-11-11 Yoo; Seo Hong Amine acid salt compounds and process for the production thereof
DE69739561D1 (de) 1996-06-13 2009-10-15 Sumitomo Chemical Co Piperidin Derivative als Zwischenprodukte zur Herstellung von Paroxetine und Verfahren zu ihrer Herstellung
US20020151729A1 (en) * 1997-02-26 2002-10-17 Cheng Wen J. Novel process for the preparation of form 1 ranitidine hydrochloride
IE990387A1 (en) * 1998-06-17 2000-12-13 Russinsky Ltd A ranitidine base water adduct
IT1317858B1 (it) 2000-02-29 2003-07-15 Pharmexcel S R L Allomorfo del cloridrato dell'isomero z di derivato dialchilamminofurano, procedimento per la sua produzione e composizione
DE102006015960A1 (de) * 2006-04-04 2007-10-11 Qiagen Gmbh Gemisch reversibel inhibierter Enzyme
JP2013533866A (ja) * 2010-06-17 2013-08-29 ドクター レディズ ラボラトリーズ リミテッド 3−アミノピペリジンジヒドロクロリドの単一の鏡像異性体を調製するための方法
WO2015155297A1 (en) 2014-04-11 2015-10-15 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical combinations of dabigatran and h2-receptor antagonists
WO2015169957A1 (en) 2014-05-09 2015-11-12 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical combinations of rivaroxaban and h2-receptor antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1181084A (en) * 1980-01-08 1985-01-15 Glaxo Group Limited Process for the preparation of a furan derivative
GB2084580B (en) * 1980-10-01 1984-07-04 Glaxo Group Ltd Aminoalkyl furan derivative
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
DE3211127C1 (de) * 1982-03-26 1983-08-11 Degussa Ag, 6000 Frankfurt Verfahren zur Gewinnung von S-(Carboxymethyl)-(R)-cystein und S-(Carboxymethyl)-(S)-cystein
US4613688A (en) * 1982-04-02 1986-09-23 Showa Denko Kabushiki Kaisha Optical resolution process for DL-cysteine
JPH0730064B2 (ja) * 1989-08-17 1995-04-05 協和醗酵工業株式会社 フラン誘導体

Also Published As

Publication number Publication date
AU674006B2 (en) 1996-12-05
ATE119894T1 (de) 1995-04-15
ZA934995B (en) 1994-02-11
HU9301980D0 (en) 1993-09-28
DE69300088T2 (de) 1995-08-31
HUT68736A (en) 1995-04-27
EP0626381A1 (de) 1994-11-30
CA2099530C (en) 2002-10-08
NZ260551A (en) 1995-02-24
ES2069446T3 (es) 1995-05-01
HU214334B (hu) 1998-03-02
EP0626381B1 (de) 1995-03-15
CA2099530A1 (en) 1995-01-03
AU4179493A (en) 1995-01-27
DE69300088D1 (de) 1995-04-20
US5338871A (en) 1994-08-16

Similar Documents

Publication Publication Date Title
DK0626381T3 (da) Fremstilling af form 1 ranitidinhydrochlorid
DE3852931D1 (de) Flüssigkristalline Cyclopropyl-alkyl- oder -alkenyl-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung in flüssig-kristallinen Mischungen.
RU94046169A (ru) Гетероциклические соединения, способ их получения, способ разделения оптических изомеров, фармкомпозиция, способ лечения
NO20012876D0 (no) Nye trisykliske forbindelser og medikamentsammensetninger inneholdende slike
ATE130604T1 (de) Neue arylethylaminderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
PT81855B (pt) Processo de preparacao de arilciclobutilalquilaminas e de composicoes farmaceuticas que as contem
DE69122866D1 (de) Herstellung von substituierten piperidinen
FI942457A0 (fi) Substituoitujen piperidiinien valmistus
DK0450420T3 (da) Heterocyclisk substituerede dihydropyridiner, fremgangsmåde til deres fremstilling og deres anvendelse i lægemidler
DK0397044T3 (da) Hidtil ukendte arylsulfonamider, lægemidler, der indeholder disse forbindelser, og fremgangsmåder til deres fremstilling
DK0564358T3 (da) 3-aminochroman-spiro-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende sådanne
KR910004562A (ko) 신규 아릴피롤 화합물 및 이들의 제조방법
TW231289B (en) Preparation of form 1 ranitidine hydrochloride
ES2075262T3 (es) Resinas de poliester insaturado.
EP0388977A3 (de) Polycyclische Amine zur Verwendung als Zerebrovaskulärer Wirkstoff
DK0397042T3 (da) Fremstilling af isoquinolinderivater
DE3887102D1 (de) Substituierte Derivate von 20,21-Dinoreburnamenin, Verfahren zur Herstellung und so hergestellte Zwischenprodukte, ihre Verwendung als Arzneimittel und diese enthaltende pharmazeutische Zusammenstellungen.
ES2084756T3 (es) Nuevos derivados de piridilo, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
FI903701A0 (fi) Reninhaemmande amino-oligohydroxiderivat.
ATE42291T1 (de) Spiro(indolo(1,7-ab>(1,5>benzodiazepin-2,4'piperidine> und zwischenprodukte, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel.
KR950003281A (ko) 제1형 염산라니티딘의 제조방법
KR940021524A (ko) 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법
DK1150968T3 (da) Fremgangsmåde til fremstilling af phytosteriner
EP0342666A3 (de) Biphenylverbindungen, Verfahren zu ihrer Herstellung sowie sie enthaltende flüssigkristalline Zusammensetzungen und lichtausschaltende Elemente
KR890016101A (ko) 이미드 결합을 지닌 수지의 제조합법 및 그 수지로 이루어진 난연제